| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 114, 998-1004, Copyright © 1984 by Endocrine Society
ARTICLES |
JL Leonard, JE Silva, MM Kaplan, SA Mellen, TJ Visser and PR Larsen
Cerebrocortical and pituitary iodothyronine 5'-deiodinases produce 50% or more of the T3 found in these tissues and show rapid 3- to 5-fold changes in response to changes in the thyroid status. Since many T3 responses are initiated in the cell nucleus and require protein synthesis, we studied the influence of cycloheximide and actinomycin D on the acute T3 suppression of cerebrocortical and pituitary 5'- deiodinase activities in hypothyroid rats. Cycloheximide inhibited protein synthesis by more than 95%, but did not prevent the rapid (4-h) T3-mediated decreases in 5'-deiodinase activity. In the presence of cycloheximide, T3 decreased enzyme activity by more than 85%, with a t1/2 of approximately 70 min in the cerebral cortex and about 110 min in the pituitary. In vitro, neither T3 nor cycloheximide in large excess had any effect on enzyme activity. In cycloheximide-treated rats, cerebrocortical 5'-deiodinase activity decreased with a fractional turnover rate (k) of 1.2 h-1 in euthyroid and 0.07 h-1 in hypothyroid rats, respectively, with corresponding steady state enzyme levels of 18 +/- 3 and 145 +/- 9 U/mg protein. The resulting production rates of cerebrocortical 5'-deiodinase were 22 and 10 U/mg protein X h. Actinomycin D failed to alter either the cerebrocortical 5'-deiodinase in euthyroid rats in 4 h or the inhibitory effect of T3, but inhibited RNA synthesis by more than 70%. These data indicate that the T3- dependent fall in cerebrocortical 5'-deiodinase is mediated by a posttranscriptional mechanism that ultimately increases the rate of degradation/inactivation of the enzyme.
This article has been cited by other articles:
![]() |
M. S Wagner, S. M Wajner, J. M Dora, and A. L. Maia Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice J. Endocrinol., June 1, 2007; 193(3): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Farwell, S. A. Dubord-Tomasetti, A. Z. Pietrzykowski, and J. L. Leonard Dynamic Nongenomic Actions of Thyroid Hormone in the Developing Rat Brain Endocrinology, May 1, 2006; 147(5): 2567 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morimura, K. Tsunekawa, T. Kasahara, K. Seki, T. Ogiwara, M. Mori, and M. Murakami Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin Endocrinology, April 1, 2005; 146(4): 2077 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yasuzawa-Amano, N. Toyoda, A. Maeda, A. Kosaki, Y. Mori, T. Iwasaka, and M. Nishikawa Expression and Regulation of Type 2 Iodothyronine Deiodinase in Rat Aorta Media Endocrinology, December 1, 2004; 145(12): 5638 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. J. S. Wassen, W. Klootwijk, E. Kaptein, D. J. Duncker, T. J. Visser, and G. G. J. M. Kuiper Characteristics and Thyroid State-Dependent Regulation of Iodothyronine Deiodinases in Pigs Endocrinology, September 1, 2004; 145(9): 4251 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Friedrichsen, S. Christ, H. Heuer, M. K. H. Schafer, A. Mansouri, K. Bauer, and T. J. Visser Regulation of Iodothyronine Deiodinases in the Pax8-/- Mouse Model of Congenital Hypothyroidism Endocrinology, March 1, 2003; 144(3): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor Endocrinology, April 1, 2002; 143(4): 1190 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mizuma, M. Murakami, and M. Mori Thyroid Hormone Activation in Human Vascular Smooth Muscle Cells : Expression of Type II Iodothyronine Deiodinase Circ. Res., February 16, 2001; 88(3): 313 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bates, Vickie. L. Spate, J. S. Morris, D. L. St. Germain, and V. A. Galton Effects of Selenium Deficiency on Tissue Selenium Content, Deiodinase Activity, and Thyroid Hormone Economy in the Rat during Development Endocrinology, July 1, 2000; 141(7): 2490 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Canettieri, F. S. Celi, G. Baccheschi, L. Salvatori, M. Andreoli, and M. Centanni Isolation of Human Type 2 Deiodinase Gene Promoter and Characterization of a Functional Cyclic Adenosine Monophosphate Response Element Endocrinology, May 1, 2000; 141(5): 1804 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steinsapir, A. C. Bianco, C. Buettner, J. Harney, and P. R. Larsen Substrate-Induced Down-Regulation of Human Type 2 Deiodinase (hD2) Is Mediated through Proteasomal Degradation and Requires Interaction with the Enzyme's Active Center Endocrinology, March 1, 2000; 141(3): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hosoi, M. Murakami, H. Mizuma, T. Ogiwara, M. Imamura, and M. Mori Expression and Regulation of Type II Iodothyronine Deiodinase in Cultured Human Skeletal Muscle Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3293 - 3300. [Abstract] [Full Text] |
||||
![]() |
J. L. Leonard, D. M. Leonard, M. Safran, R. Wu, M. L. Zapp, and A. P. Farwell The Mammalian Homolog of the Frog Type II Selenodeiodinase Does Not Encode a Functional Enzyme in the Rat Endocrinology, May 1, 1999; 140(5): 2206 - 2215. [Abstract] [Full Text] |
||||
![]() |
S.-W. Kim, J. W. Harney, and P. R. Larsen Studies of the Hormonal Regulation of Type 2 5'-Iodothyronine Deiodinase Messenger Ribonucleic Acid in Pituitary Tumor Cells Using Semiquantitative Reverse Transcription-Polymerase Chain Reaction Endocrinology, December 1, 1998; 139(12): 4895 - 4905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Diano, F. Naftolin, F. Goglia, and T. L. Horvath Fasting-Induced Increase in Type II Iodothyronine Deiodinase Activity and Messenger Ribonucleic Acid Levels Is Not Reversed by Thyroxine in the Rat Hypothalamus Endocrinology, June 1, 1998; 139(6): 2879 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Burmeister, J. Pachucki, and D. L. St. Germain Thyroid Hormones Inhibit Type 2 Iodothyronine Deiodinase in the Rat Cerebral Cortex by Both Pre- and Posttranslational Mechanisms Endocrinology, December 1, 1997; 138(12): 5231 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Schuur, F. M. Boekhorst, A. Brouwer, and T. J. Visser Extrathyroidal Effects of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on Thyroid Hormone Turnover in Male Sprague-Dawley Rats Endocrinology, September 1, 1997; 138(9): 3727 - 3734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Oppenheimer and H. L. Schwartz Molecular Basis of Thyroid Hormone-Dependent Brain Development Endocr. Rev., August 1, 1997; 18(4): 462 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Tu, S.-W. Kim, D. Salvatore, T. Bartha, G. Legradi, P. R. Larsen, and R. M. Lechan Regional Distribution of Type 2 Thyroxine Deiodinase Messenger Ribonucleic Acid in Rat Hypothalamus and Pituitary and Its Regulation by Thyroid Hormone Endocrinology, August 1, 1997; 138(8): 3359 - 3368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Becker, K. C. Stephens, J. C. Davey, M. J. Schneider, and V. A. Galton The Type 2 and Type 3 Iodothyronine Deiodinases Play Important Roles in Coordinating Development in Rana catesbeiana Tadpoles Endocrinology, July 1, 1997; 138(7): 2989 - 2997. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orozco, J. E. Silva, and C. Valverde-R Rainbow Trout Liver Expresses Two Iodothyronine Phenolic Ring Deiodinase Pathways with the Characteristics of Mammalian Types I and II 5'-Deiodinases Endocrinology, January 1, 1997; 138(1): 254 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Farwell, M. Safran, S. Dubord, and J. L. Leonard Degradation and Recycling of the Substrate-binding Subunit of Type II Iodothyronine 5'-Deiodinase in Astrocytes J. Biol. Chem., July 5, 1996; 271(27): 16369 - 16374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Leonard, S. J. Stachelek, M. Safran, A. P. Farwell, T. F. Kowalik, and J. L. Leonard Cloning, Expression, and Functional Characterization of the Substrate Binding Subunit of Rat Type II Iodothyronine 5'-Deiodinase J. Biol. Chem., August 11, 2000; 275(33): 25194 - 25201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Stachelek, T. F. Kowalik, A. P. Farwell, and J. L. Leonard Myosin V Plays an Essential Role in the Thyroid Hormone-dependent Endocytosis of Type II Iodothyronine 5'-Deiodinase J. Biol. Chem., October 6, 2000; 275(41): 31701 - 31707. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |